Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer

NCT00155883 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

54

Enrollment

OTHER

Sponsor class

Stopped slow a accrul due to many competitive trials.

Conditions

Gastric Cancer

Interventions

DRUG: Taxteral
DRUG: 5-Fluorouracil
DRUG: Leucovorin

Sponsor

National Taiwan University Hospital